ORLANDO, Fla.--(BUSINESS WIRE)--Cardiovascular Sciences, Inc. (Pink Sheets:CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead in the field of the company’s primary technology, that of the prevention of adhesions following surgery. Adhesions occur any time two adjacent tissues have been injured as part of the normal healing process. For cuts on the surface of the skin, this is a good thing. But when it is between two internal organs or tissue surfaces that are not usually fused, it can cause clinically significant and serious problems. The company’s current technology and plans promise to satisfy some of the issues that are currently not addressed by the few products on the market at this time.
